Zheng Ao
Engineering · Indiana University
Publications
129
Citations
3,739
Est. group size
—
Recurring co-author estimate
Active years
15
Publishing since 2012
Zheng Ao works at the intersection of bioengineering and medicine, developing tools and materials such as nanomaterials, microfluidic devices, and cell-based therapies. Recent projects range from nanoparticle treatments for diabetic wound healing to engineering immune cells (tumor-infiltrating lymphocytes) to attack hard-to-treat cancers like chondrosarcoma. The work also touches on energy-storage materials such as supercapacitors.
Publication activity has generally grown over the past decade, with a notable increase in the most recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Additional file 2 of Functional ferritin-mimetic iron homeostasis nanoregulator to suppress ferroptosis and promote angiogenesis as a new therapeutic strategy for diabetic wound healing
Figshare · 2026
- Functional ferritin-mimetic iron homeostasis nanoregulator to suppress ferroptosis and promote angiogenesis as a new therapeutic strategy for diabetic wound healing
Figshare · 2026
- IL17 signaling promotes oocyte developmental competence acquisition during maturation
Cellular & Molecular Biology Letters · 2026
- Functional ferritin-mimetic iron homeostasis nanoregulator to suppress ferroptosis and promote angiogenesis as a new therapeutic strategy for diabetic wound healing
Journal of Nanobiotechnology · 2026
- High-performance aqueous asymmetric potassium-ion supercapacitors using core-shell layered bimetallic hydroxides fabricated from bimetallic metal organic framework via hydrothermal etching
SSRN Electronic Journal · 2026
- High-performance aqueous asymmetric potassium-ion supercapacitors using core-shell layered bimetallic hydroxides fabricated from bimetallic metal organic framework via hydrothermal etching
SSRN Electronic Journal · 2026
- Supplementary Figure S6 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Supplementary Figure S1 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Supplementary Video S3 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Data from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Supplementary Table S1 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Supplementary Figure S10 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Supplementary Figure S5 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Supplementary Video S2 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- Supplementary Table S2 from Potent Cytotoxic Tumor-Infiltrating Lymphocytes Can Be Generated from Immune-Excluded Chondrosarcomas Using Regulatable Membrane-Bound IL15
2026
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Figshare×6
- International Journal of Nanomedicine×5
- Analytical Chemistry×4
- Lab on a Chip×4
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile